Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions-Reference-Cited by-同舟云学术

Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions

Published:2019-08-18 Issue:11 Volume:28 Page:1457-1463
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Bonaldo Giulia¹,Andriani Luisa Anna¹,D'Annibali Ottavio¹,Motola Domenico¹^ORCID,Vaccheri Alberto¹

Affiliation:

1. Unit of Pharmacology, Department of Medical and Surgical SciencesUniversity of Bologna Bologna Italy

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4873

Reference23 articles.

1. ECDC.Antimicrobial consumption rates by country. Available:http://ecdc.europa.eu/en/healthtopics/antimicrobial‐resistance‐and‐consumption/antimicrobial‐consumption/esac‐net‐database/Pages/Antimicrobial‐consumption‐rates‐by‐country.aspx. Accessed 01 Mar 2018.

2. Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study

3. Concomitant Risk Factors in Reports of Torsades de Pointes Associated with Macrolide Use: Review of the United States Food and Drug Administration Adverse Event Reporting System

4. Potentially Fatal Interaction Between Azithromycin and Disopyramide

5. A case of QT‐interval prolongation precipitated of QT‐interval prolongation precipitated;Matsunaga N;N Z Med J.,2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications;Phytomedicine;2024-09

2. A green and economically efficient adsorbent made by longan seed for the treatment of fluoroquinolone antibiotics in water;Journal of Cleaner Production;2024-08

3. Pharmacovigilance Strategies to Address Resistance to Antibiotics and Inappropriate Use—A Narrative Review;Antibiotics;2024-05-16

4. Long-term Cardiovascular Adverse Events Induced by Fluoroquinolones: A Retrospective Case–control Study;Journal of Cardiovascular Pharmacology;2023-11

5. Community-acquired pneumonia: antibiotic therapy approach after the COVID-19 pandemic. A review;Consilium Medicum;2023-10-14